Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incentives Plus Bupropion for Smoking in Schizophrenics
NCT00136760Phase 2Completed
- Sponsor
- Brown University
- Start
- Sep 2003
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupropion in Tobacco Use Disorder (TUD) (4 arms), sponsored by Brown University. Primary endpoint: Urinary Cotinine at 3 weeks. Started Sep 2003; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00136760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136760.